BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33411955)

  • 1. Colorectal cancer risk variants rs10161980 and rs7495132 are associated with cancer survival outcome by a recessive mode of inheritance.
    He Y; Timofeeva M; Zhang X; Xu W; Li X; Din FVN; Svinti V; Farrington SM; Campbell H; Dunlop MG; Theodoratou E
    Int J Cancer; 2021 Jun; 148(11):2774-2778. PubMed ID: 33411955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome.
    Theodoratou E; Farrington SM; Timofeeva M; Din FV; Svinti V; Tenesa A; Liu T; Lindblom A; Gallinger S; Campbell H; Dunlop MG
    Br J Cancer; 2018 Oct; 119(8):988-993. PubMed ID: 30135471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of common genetic variants associated with colorectal cancer risk on survival outcomes after diagnosis: A large population-based cohort study.
    He Y; Theodoratou E; Li X; Din FVN; Vaughan-Shaw P; Svinti V; Farrington SM; Campbell H; Dunlop MG; Timofeeva M
    Int J Cancer; 2019 Nov; 145(9):2427-2432. PubMed ID: 31271446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the Angiogenesis-Related Genes
    Scherer D; Deutelmoser H; Balavarca Y; Toth R; Habermann N; Buck K; Kap EJ; Botma A; Seibold P; Jansen L; Lorenzo Bermejo J; Weigl K; Benner A; Hoffmeister M; Ulrich A; Brenner H; Burwinkel B; Chang-Claude J; Ulrich CM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility variants associated with colorectal cancer prognosis.
    Abulí A; Lozano JJ; Rodríguez-Soler M; Jover R; Bessa X; Muñoz J; Esteban-Jurado C; Fernández-Rozadilla C; Carracedo A; Ruiz-Ponte C; Cubiella J; Balaguer F; Bujanda L; Reñé JM; Clofent J; Morillas JD; Nicolás-Pérez D; Xicola RM; Llor X; Piqué JM; Andreu M; Castells A; Castellví-Bel S;
    Carcinogenesis; 2013 Oct; 34(10):2286-91. PubMed ID: 23712746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
    Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
    PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
    Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
    Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Five Common Plasminogen Activator Inhibitor-1 (
    Oh J; An HJ; Kim JO; Jun HH; Kim WR; Kim EJ; Oh D; Kim JW; Kim NK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.
    Garcia-Albeniz X; Nan H; Valeri L; Morikawa T; Kuchiba A; Phipps AI; Hutter CM; Peters U; Newcomb PA; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Carcinogenesis; 2013 Feb; 34(2):292-8. PubMed ID: 23104301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer.
    Chae YS; Kim JG; Lee SJ; Kang BW; Lee YJ; Park JY; Jeon HS; Park JS; Choi GS
    Anticancer Res; 2013 Aug; 33(8):3233-9. PubMed ID: 23898084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in noncoding PIWI-interacting RNA and colorectal cancer risk.
    Chu H; Xia L; Qiu X; Gu D; Zhu L; Jin J; Hui G; Hua Q; Du M; Tong N; Chen J; Zhang Z; Wang M
    Cancer; 2015 Jun; 121(12):2044-52. PubMed ID: 25740697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Binding Site Polymorphisms of the Long-Chain Noncoding RNA
    Yang Q; Zheng W; Shen Z; Huang G; Yang G
    Genet Test Mol Biomarkers; 2020 May; 24(5):239-248. PubMed ID: 32349546
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic polymorphisms are associated with the risk of gastric and colorectal cancers in a Han Chinese population.
    Wang N; Qiao Q; Bao G; Wu T; Li Y; Li J; Lu J; He X
    Oncotarget; 2017 Apr; 8(17):28805-28811. PubMed ID: 28404937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in non-coding RNAs and risk of colorectal cancer: A systematic review and meta-analysis.
    Alidoust M; Hamzehzadeh L; Rivandi M; Pasdar A
    Crit Rev Oncol Hematol; 2018 Dec; 132():100-110. PubMed ID: 30447914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA H19 gene rs2839698 polymorphism is associated with a decreased risk of colorectal cancer in a Chinese Han population: A case-control study.
    Yu B; Chen J; Hou C; Zhang L; Jia J
    J Clin Lab Anal; 2020 Aug; 34(8):e23311. PubMed ID: 32207861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
    Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
    Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
    Vaughan-Shaw PG; Zgaga L; Ooi LY; Theodoratou E; Timofeeva M; Svinti V; Walker M; O'Sullivan F; Ewing A; Johnston S; Din FVN; Campbell H; Farrington SM; Dunlop MG
    Gut; 2020 Jan; 69(1):103-111. PubMed ID: 31023832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.